Showing results (91-100 of 400) with videos related to

Sort By:
Pageof 40
Journal of the National Cancer Institute|September 15, 1993
Natural killer cells and bone marrow transplantationW J Murphy, C W Reynolds, P Tiberghien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Vinblastine for recurrent Hodgkin's disease following autologous bone marrow transplantR Little, R E Wittes, D L Longo, et al.
The Journal of Biological Chemistry|December 2, 1994
Phosphorylation of NF-KB1-p50 is involved in NF-kappa B activation and stable DNA bindingC C Li, R M Dai, E Chen, et al.
Cancer Research|January 1, 1992
Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in vitro versus in vivo activityR L Hornung, J W Pearson, M Beckwith, et al.
Journal of Neuroscience Research|January 1, 1987
Development of innervation within syngeneic thymus tissue transplanted under the kidney capsule of the nude mouse: a light and ultrastructural microscope studyK Bulloch, M R Cullen, R H Schwartz, et al.
Journal of the National Cancer Institute|November 20, 1991
Antineoplastic dolastatins: potent inhibitors of hematopoietic progenitor cellsS E Jacobsen, F W Ruscetti, D L Longo, et al.
The Journal of Experimental Medicine|August 4, 1999
Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcriptionR K Srivastava, C Y Sasaki, J M Hardwick, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 1999
Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosisR K Srivastava, Q S Mi, J M Hardwick, et al.
Blood|September 1, 1995
Leukemia inhibitory factor induces interleukin-8 and monocyte chemotactic and activating factor in human monocytes: differential regulation by interferon-gammaT Musso, R Badolato, D L Longo, et al.
Journal of the National Cancer Institute|September 6, 1995
Tumor antigen-specific immunization of bone marrow transplantation donors as adoptive therapy against established tumorR L Hornung, D L Longo, O C Bowersox, et al.
Pageof 40